Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Lymphatic Diseases: early-phase trial registry

2 of 7 indexed Lymphatic Diseases trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Lymphatic Diseases: 7 US clinical trials tracked, 2 recruiting.

Lymphatic Diseases is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is UNC Lineberger Comprehensive Cancer Center, running 5 of these trials.

Enrollment posture brief

Registry condition lymphatic-diseases

OPEN 2 | RECR 29% | LATE 0 | EARLY 5 | RANK #2497 | SPON 5

Volume-matched condition peers

Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Lymphatic Diseases (this)29%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Lymphatic Diseases

Lymphatic Diseases lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Lymphatic Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Lymphatic Diseases is recruiting below its size-band peers.

    2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Lymphatic Diseases research.

    UNC Lineberger Comprehensive Cancer Center accounts for 5 of 7 trials (71.4%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Lymphatic Diseases trials plan to enrol fewer than 100 people.

    Median target enrolment is 38 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.

  4. Lymphatic Diseases research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 14Phase 21

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 1

Top Sponsors

UNC Lineberger Comprehensive Cancer Center 5 trials
Masonic Cancer Center, University of Minnesota 1 trials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1 trials

Named interventions

Most-linked intervention names on Lymphatic Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Bendamustine Drug
2 trials
Fludarabine Drug
2 trials
ATLCAR.CD30 cells Drug
1 trials
ATLCAR.CD30 cells Biological
1 trials
ALTCAR.CD30 cells Biological
1 trials
ATLCAR.CD30.CCR4 cells Biological
1 trials
CHEP Drug
1 trials
AP1903 Drug
1 trials

US sites by state

Facility locations filed on Lymphatic Diseases trials. A trial with sites in several states counts in each.

North Carolina 5 trials
Pennsylvania 1 trials
Minnesota 1 trials
Maryland 1 trials
Massachusetts 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Lymphatic Diseases page

7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lymphatic Diseases condition card totals 7 registered trials; most-linked intervention Bendamustine; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.